Global Influenza Vaccine Market 2024-2028

Global Influenza Vaccine Market 2024-2028

Global Influenza Vaccine Market 2024-2028

The influenza vaccine market is forecasted to grow by USD 3761.8 mn during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the influenza vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence and incidence of influenza, rising awareness about influenza vaccination, and initiation of immunization programs and research activities.

Technavio's influenza vaccine market is segmented as below:

By Distribution Channel

• Hospitals and pharmacies
• Government and institutional
• Others

By Type

• Live attenuated influenza vaccines
• Recombinant influenza vaccines

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the need for revaccination as one of the prime reasons driving the influenza vaccine market growth during the next few years. Also, surge in number of genetic characterization studies on influenza virus and increase in global travel will lead to sizable demand in the market.

The report on the influenza vaccine market covers the following areas:

• Influenza vaccine market sizing
• Influenza vaccine market forecast
• Influenza vaccine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza vaccine market vendors that include Altimmune Inc., AstraZeneca Plc, Baxter International Inc., BioDiem Ltd., BiondVax Pharmaceuticals Ltd., CSL Ltd., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., FluGen Inc., GlaxoSmithKline Plc, Mitsubishi Chemical Group Corp., Novavax Inc., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Shijiazhuang Yiling Pharmaceutical Co Ltd., SK Chemicals Co. Ltd., Vaccitech Plc, Vaxart Inc., and Vaxine Pty Ltd.. Also, the influenza vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.